Zhongjun Wu
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
Papers in
-
- MicroRNA in disease regulation 29
- Cancer-related molecular mechanisms research 26
- Hepatology 19
- Liver Disease and Transplantation 12
Zhongjun Wu
112 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 669
- Hepatology 336
- Immunology 384
- Molecular Biology 1000
- Epidemiology 387
Countries citing papers authored by Zhongjun Wu
This map shows the geographic impact of Zhongjun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongjun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongjun Wu more than expected).
Fields of papers citing papers by Zhongjun Wu
This network shows the impact of papers produced by Zhongjun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongjun Wu. The network helps show where Zhongjun Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhongjun Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 7 | |
| 7 | 2025 | 3 | |
| 8 | 2024 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 7 | |
| 12 | 2023 | 3 | |
| 13 | 2022 | 3 | |
| 14 | 2020 | 2 | |
| 15 | 2020 | 21 | |
| 16 | 2018 | 8 | |
| 17 | 2018 | 12 | |
| 18 | 2018 | 48 | |
| 19 | 2017 | 78 | |
| 20 | [Over-expression of transcription factor 21 inhibits the proliferation and migration and promotes apoptosis of SMMC-7721 cells]. | 2015 | 2 |
About Zhongjun Wu
Zhongjun Wu is a scholar working on Cancer Research, Hepatology, Immunology, Molecular Biology and Geriatrics and Gerontology, having authored 116 papers that have together received 1.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (29 papers), Cancer-related molecular mechanisms research (26 papers), Organ Transplantation Techniques and Outcomes (18 papers), Circular RNAs in diseases (16 papers), RNA modifications and cancer (14 papers), Liver Disease and Transplantation (12 papers), Liver Disease Diagnosis and Treatment (11 papers) and Autophagy in Disease and Therapy (7 papers). The work is most often cited by research in Cancer Research (669 citations), Hepatology (336 citations), Immunology (384 citations), Molecular Biology (1000 citations) and Epidemiology (387 citations). Zhongjun Wu has collaborated with scholars based in China, United States and Panama. Frequent co-authors include Xufu Wei, Daofeng Zheng, Tong Mou, Zuotian Huang, Chengyong Tang, Ai Shen, Junliang Pu, Rui Liu, Yunhai Luo and Guosheng Ren. Their work appears in journals such as Frontiers in Immunology, Biochemical and Biophysical Research Communications, International Immunopharmacology, Acta Biochimica et Biophysica Sinica and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.